Pacira Long Term Investments vs Net Receivables Analysis

PCRX Stock  USD 30.82  0.69  2.19%   
Pacira Pharmaceuticals financial indicator trend analysis is much more than just breaking down Pacira Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pacira Pharmaceuticals is a good investment. Please check the relationship between Pacira Pharmaceuticals Long Term Investments and its Net Receivables accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.

Long Term Investments vs Net Receivables

Long Term Investments vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pacira Pharmaceuticals Long Term Investments account and Net Receivables. At this time, the significance of the direction appears to have no relationship.
The correlation between Pacira Pharmaceuticals' Long Term Investments and Net Receivables is 0.0. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Pacira Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Pacira Pharmaceuticals' Long Term Investments and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Pacira Pharmaceuticals are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Long Term Investments i.e., Pacira Pharmaceuticals' Long Term Investments and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.0
Relationship DirectionFlat 
Relationship StrengthInsignificant

Long Term Investments

Long Term Investments is an item on the asset side of Pacira Pharmaceuticals balance sheet that represents investments Pacira Pharmaceuticals intends to hold for over a year. Pacira Pharmaceuticals long term investments may include different instruments such as stocks, bonds, real estate and cash.

Net Receivables

Most indicators from Pacira Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pacira Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.At this time, Pacira Pharmaceuticals' Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.33 in 2024, whereas Selling General Administrative is likely to drop slightly above 63.1 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense31.8M40.0M23.8M16.1M
Depreciation And Amortization13.6M61.4M75.6M79.4M

Pacira Pharmaceuticals fundamental ratios Correlations

0.790.680.960.80.920.220.950.320.580.650.980.840.560.970.780.960.610.650.360.980.940.720.840.920.92
0.790.690.680.870.8-0.10.710.120.510.780.760.540.350.80.680.750.580.620.080.80.740.40.740.870.61
0.680.690.510.780.670.110.560.060.120.90.60.820.650.560.790.520.420.450.150.590.550.230.560.810.44
0.960.680.510.660.870.220.910.380.60.480.960.760.470.930.660.980.60.660.390.930.960.80.810.790.98
0.80.870.780.660.77-0.060.670.350.460.870.780.690.390.770.680.720.350.39-0.070.790.690.430.610.880.62
0.920.80.670.870.770.290.910.160.630.60.880.80.670.890.820.850.730.760.470.90.860.60.930.940.79
0.22-0.10.110.22-0.060.290.28-0.340.350.00.110.290.360.240.50.140.30.270.70.230.190.080.380.230.15
0.950.710.560.910.670.910.280.30.610.450.940.780.630.960.720.90.570.60.450.960.850.670.810.880.86
0.320.120.060.380.350.16-0.340.30.040.080.460.340.160.29-0.160.37-0.34-0.32-0.420.310.250.4-0.130.180.42
0.580.510.120.60.460.630.350.610.040.190.550.280.20.670.520.60.340.410.50.650.620.30.670.540.55
0.650.780.90.480.870.60.00.450.080.190.570.660.370.560.730.520.390.42-0.050.590.550.290.520.780.43
0.980.760.60.960.780.880.110.940.460.550.570.780.50.960.650.980.530.580.230.970.930.760.760.870.94
0.840.540.820.760.690.80.290.780.340.280.660.780.810.720.80.710.440.460.390.750.690.550.650.830.72
0.560.350.650.470.390.670.360.630.160.20.370.50.810.480.680.380.340.340.560.510.390.220.530.660.35
0.970.80.560.930.770.890.240.960.290.670.560.960.720.480.740.940.580.610.341.00.890.710.820.90.88
0.780.680.790.660.680.820.50.72-0.160.520.730.650.80.680.740.630.640.650.620.750.670.360.830.870.57
0.960.750.520.980.720.850.140.90.370.60.520.980.710.380.940.630.590.660.280.950.970.780.790.810.97
0.610.580.420.60.350.730.30.57-0.340.340.390.530.440.340.580.640.590.980.550.570.650.50.880.610.56
0.650.620.450.660.390.760.270.6-0.320.410.420.580.460.340.610.650.660.980.550.60.740.530.90.630.62
0.360.080.150.39-0.070.470.70.45-0.420.5-0.050.230.390.560.340.620.280.550.550.330.350.150.630.320.3
0.980.80.590.930.790.90.230.960.310.650.590.970.750.511.00.750.950.570.60.330.90.710.820.910.89
0.940.740.550.960.690.860.190.850.250.620.550.930.690.390.890.670.970.650.740.350.90.750.840.790.95
0.720.40.230.80.430.60.080.670.40.30.290.760.550.220.710.360.780.50.530.150.710.750.560.520.83
0.840.740.560.810.610.930.380.81-0.130.670.520.760.650.530.820.830.790.880.90.630.820.840.560.840.74
0.920.870.810.790.880.940.230.880.180.540.780.870.830.660.90.870.810.610.630.320.910.790.520.840.71
0.920.610.440.980.620.790.150.860.420.550.430.940.720.350.880.570.970.560.620.30.890.950.830.740.71
Click cells to compare fundamentals

Pacira Pharmaceuticals Account Relationship Matchups

Pacira Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets831.1M1.3B2.1B1.7B1.6B1.7B
Other Current Liab18.2M14.7M117.9M89.8M64.2M36.3M
Total Current Liabilities107.7M253.3M521.1M147.8M97.4M123.5M
Total Stockholder Equity354.9M619.7M730.4M775.0M870.1M913.6M
Other Liab21.5M17.4M77.6M37.8M43.5M24.9M
Property Plant And Equipment Net142.8M211.2M264.8M254.4M234.9M120.3M
Net Debt273.7M441.2M543.3M659.3M432.7M454.4M
Retained Earnings(399.4M)(253.9M)(211.9M)(148.8M)(106.8M)(112.1M)
Accounts Payable12.8M10.4M10.5M15.2M15.7M10.4M
Cash78.2M100.0M585.6M104.1M153.3M117.4M
Non Current Assets Total422.5M622.9M1.2B1.2B1.1B1.1B
Non Currrent Assets Other11.0M74.5M76.4M27.2M36.0M37.9M
Other Assets971K290.1M153.4M160.3M1.00.95
Long Term Debt306.0M313.0M674.5M655.8M513.8M539.5M
Cash And Short Term Investments292.0M521.7M656.4M288.7M278.6M237.8M
Net Receivables47.5M53.0M96.3M98.4M105.6M110.8M
Common Stock Shares Outstanding41.5M43.7M45.6M46.5M52.0M35.9M
Short Term Investments213.7M421.7M70.8M184.5M125.3M137.9M
Liabilities And Stockholders Equity831.1M1.3B2.1B1.7B1.6B1.7B
Non Current Liabilities Total368.4M401.5M823.8M758.4M606.9M637.2M
Inventory58.3M64.7M98.6M96.1M104.4M109.6M
Other Current Assets10.8M12.3M14.8M15.2M21.5M22.6M
Other Stockholder Equity754.0M873.2M942.1M924.1M976.6M599.8M
Total Liab476.1M654.8M1.3B906.2M704.3M396.5M
Property Plant And Equipment Gross142.8M211.2M264.8M254.4M370.3M388.8M
Total Current Assets408.6M651.6M866.0M498.3M510.0M331.8M
Accumulated Other Comprehensive Income322K318K167K(380K)247K259.4K
Short Term Debt4.9M157.1M382.6M42.8M17.4M16.6M
Common Stock42K44K45K46K52.9K35.1K
Property Plant Equipment104.7M136.7M264.8M254.4M292.5M307.2M
Short Long Term Debt Total351.9M541.1M1.1B763.4M586.0M348.5M
Net Tangible Assets151.0M423.6M(38.7M)71.2M81.9M77.8M
Retained Earnings Total Equity(388.2M)(399.4M)(253.9M)(211.9M)(190.7M)(200.2M)
Long Term Debt Total276.2M290.6M306.0M313.0M360.0M240.7M
Capital Surpluse709.7M754.0M873.2M942.1M1.1B685.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pacira Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacira Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacira Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacira Pharmaceuticals Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Pacira Stock analysis

When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.291
Earnings Share
1.51
Revenue Per Share
14.706
Quarterly Revenue Growth
0.042
Return On Assets
0.0376
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.